Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 20:30:48 09/07/2025 BST			5-day change	1st Jan Change
787.40 ^USD	+1.25%		+0.94%	+1.89%

04:04pm	Öhman Health and New Technology Fund Rises 3.9% in June - Camurus Surges After Eli Lilly Partnership	FW
03:55pm	Eli Lilly Seen Benefiting From Higher Zepbound Sales in Q2, BofA Says	MT

Wall Street futures dip as Mideast conflict continues

Published on 17/06/2025 at 12:40

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Eli Lilly and Company

Öhman Health and New Technology Fund Rises 3.9% in June - Camurus Surges After Eli Lilly Partnership	04:04pm	FW
Eli Lilly Seen Benefiting From Higher Zepbound Sales in Q2, BofA Says	03:55pm	MT
Eli Lilly: new recommended dosage for Kisunla	01:29pm	CF
Eli Lilly and Company Announces FDA Approves Updated Label for Lilly's Kisunla (donanemab-azbt) with New Dosing in Early Symptomatic Alzheimer's Disease	12:35pm	CI
Eli Lilly Gets FDA Approval for Updated Kisunla Dosing for Alzheimer's	12:24pm	MT
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	12:01pm	RE
Eli Lilly FDA approves updated label for Kisunla	11:52am	RE
US FDA approves gradual dosing for Lilly Alzheimer's drug	11:46am	RE
Trump says pharmaceutical tariffs could reach 200%	07-08	RE
Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs	07-08	MT
WeightWatchers names new medical chief, plans to offer menopause therapy and support	07-08	RE
Sector Update: Tech	07-07	MT
Alphabet's Isomorphic Labs Readying to Test AI-Designed Drugs on People	07-07	MT
Demand for obesity drugs shoots up in India as Lilly, Novo vie for market share	07-07	RE
Demand for obesity drugs shoots up in India as Lilly, Novo vie for market share	07-07	RE
How Novo Nordisk misread the US market for its weight loss sensation	07-01	RE
Novo Nordisk Executives Ignored Warnings Against Wegovy Launch	07-01	MT
China's Innogen expects to complete weight-loss drug trials next year	07-01	RE
Novo Nordisk Executives Ignored Warnings Against Wegovy Launch	07-01	MT
INmune Bio's Alzheimer's drug misses mid-stage goal, shares sink to record low	06-30	RE
INmune Bio's Alzheimer's drug misses mid-stage goal, shares sink to record low	06-30	RE
Eli Lilly Wins Indian Regulatory Nod for Mounjaro Rollout	06-29	MT
Stung by high prices, Americans make their own weight-loss drugs	06-27	RE
Eli Lilly 'Clear Leader in Obesity' Drugs, UBS Says; Raises 2025 Earnings Forecast	06-27	MT
Biogen's Leqembi Has 'Meaningful Advantages' Over Lilly's Kisunla, Leading to Potential Billions in Sales, RBC Says	06-27	MT

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (65.5%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.4%); - immunology diseases (9.8%); - neurology (3.3%): primarily drugs used in treating depression and schizophrenia; - other (2%). Net sales are distributed geographically as follows: the United States (67.4%), Europe (15.4%), Japan (4%), China (3.7%) and other (9.5%).

Employees

47,000

Sector

Pharmaceuticals

Calendar

08-07 - Q2 2025 Earnings Release

More about the company